Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. [electronic resource]
Producer: 20120827Description: 66-79 p. digitalISSN:- 1096-1186
- Acetic Acid
- Acute Disease
- Administration, Oral
- Animals
- Anti-Inflammatory Agents -- administration & dosage
- Apoptosis -- drug effects
- Cell Line
- Chitosan -- administration & dosage
- Chronic Disease
- Colitis -- chemically induced
- Colon -- drug effects
- Dextran Sulfate
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Down-Regulation
- Gastrointestinal Agents -- administration & dosage
- Humans
- Inflammation Mediators -- metabolism
- Inflammatory Bowel Diseases -- chemically induced
- Interleukin-6 -- metabolism
- Intestinal Mucosa -- drug effects
- Male
- Mice
- Mice, Inbred ICR
- NF-kappa B -- metabolism
- Oxidative Stress -- drug effects
- Permeability
- Reactive Oxygen Species -- metabolism
- Signal Transduction -- drug effects
- Time Factors
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.